The new NCCN Guidelines for Lung Cancer Screening primarily refer to non–small cell lung cancer, the most common type of lung cancer, and recommend helical low-dose computed tomography (LDCT) screening for select patients at high risk for the disease.
In addition to outlining the appropriate use of LDCT screening, the NCCN Guidelines describe risk factors for lung cancer, recommend criteria for selecting high-risk individuals for screening, provide recommendations for evaluation and follow-up of nodules found during screening, detail the accuracy of LDCT screening protocols and imaging modalities, and discuss the benefits and risks of screening.
The NCCN Guidelines for Lung Cancer Screening can be found under NCCN Guidelines for Detection, Prevention, & Risk Reduction on the NCCN.org website or at http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf.
For the complete updated versions of the NCCN Guidelines and the NCCN Drugs & Biologics Compendium (NCCN Compendium®), visit NCCN.org. To view the NCCN Guidelines for Patients™, visit NCCN.com. Finally, free NCCN Guidelines mobile apps for iPhone and Android are now available at NCCN.org/mobile. ■
